Key issues and improvements in the clinical governance of osteoporotic fractures
10.3760/cma.j.cn121113-20241121-00675
- VernacularTitle:骨质疏松性骨折临床管理的关键问题及改进
- Author:
Junjie LI
1
;
Youjia XU
Author Information
1. 苏州大学附属第二医院骨科，苏州大学附属第二医院骨质疏松症临床中心，苏州 215004
- Publication Type:Journal Article
- Keywords:
Osteoporotic fractures;
Clinical governance;
Internal fixators;
Biocompatible materials
- From:
Chinese Journal of Orthopaedics
2025;45(12):760-766
- CountryChina
- Language:Chinese
-
Abstract:
Global population aging has exacerbated the clinical management challenges of osteoporotic fractures, especially during the high-risk period of re-fracture within 2 years after fracture. Although significant progress has been made in the comprehensive management of osteoporotic fractures in China, which has improved patient prognosis. There are still many challenges in clinical practice, including the mismatch between traditional implants and osteoporotic bone structure, the clinical management bottlenecks from treatment to rehabilitation of osteoporotic fractures (such as low implementation rates of drug treatment, poor drug compliance, and inadequate rehabilitation awareness), as well as the underdevelopment and regional disparities of fracture liaison services in China. To address these challenges, we propose three strategic improvements: transitioning from a purely mechanical fixation to a combined "mechanical-biological" synergistic treatment model, optimizing a full-cycle management pathway for osteoporotic fractures based on the enhanced recovery after surgery, and developing a systematic and intelligent approach for re-fracture prevention (such as establishing exclusive management teams, constructing specialized databases, and developing intelligent data platforms). These strategies are expected to enable efficient screening, precise monitoring, and full lifecycle management of patients with osteoporotic fractures, thereby enhancing the effectiveness and precision of clinical management and offering new insights and practical pathways for improving the treatment and care of osteoporotic fractures in China.
